Genexis Biotech produces animal‑free recombinant proteins, growth factors, and serum‑free media using precision‑fermentation of engineered microbes, delivering >95 % purity and GMP‑compatible quality. The company offers custom protein design, strain and metabolic engineering, and scale‑up consulting to enable consistent cell growth for biotech, cellular‑agriculture, regenerative‑medicine, and cosmetics applications.
Funding
$461.4K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cell culture workflows still depend heavily on animal‑derived components such as fetal bovine serum (FBS) and conventional recombinant proteins, which introduce batch‑to‑batch variability, ethical concerns, and supply‑chain constraints for researchers and manufacturers.
Solution
Genexis Biotech delivers animal‑free, precision‑fermentation‑derived custom proteins, growth factors, and serum‑free media that match or exceed the performance of traditional animal‑based reagents. By engineering microbial strains and optimizing metabolic pathways, the company produces high‑purity recombinant bioproducts at scale with consistent quality. These bioproducts are formulated for robust cell growth, differentiation, and tissue‑engineering applications across cellular agriculture, regenerative medicine, biopharma, and cosmetics. Genexis also offers strain‑engineering, metabolic‑engineering, and process‑development services to accelerate customers’ scale‑up from pilot to commercial production. All products are manufactured under ISO 9001‑certified GMP‑compatible processes, ensuring traceability and regulatory compliance.
Target Audience
Primary customers are biotech firms, cell‑culture research labs, cellular‑agriculture startups, regenerative‑medicine developers, and pharmaceutical or cosmetics manufacturers requiring reliable, animal‑free reagents for product development and manufacturing.
Features
- Precision fermentation platform that uses genetically engineered microbes to synthesize recombinant proteins and growth factors without animal inputs
- Custom protein design service enabling sequence optimization, codon adaptation, and post‑translational modification tailoring for specific cell‑culture needs
- Serum‑free media formulations that replace FBS, providing defined nutrients and growth factor blends for consistent cell proliferation
- Scalable production pipeline from lab‑scale fermentation to multi‑kiloliter bioreactors, supported by strain‑ and metabolic‑engineering expertise
- End‑to‑end downstream purification (chromatography, filtration) delivering >95 % purity and low endotoxin levels suitable for GMP applications
- ISO 9001:2015 quality management system with batch‑level analytics, certificate of analysis, and traceability for regulatory submissions
- Integrated process development and scale‑up consulting to de‑risk technology transfer and reduce time‑to‑market for new bioproducts